0001752724-24-016885.txt : 20240129 0001752724-24-016885.hdr.sgml : 20240129 20240129092544 ACCESSION NUMBER: 0001752724-24-016885 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20231130 FILED AS OF DATE: 20240129 DATE AS OF CHANGE: 20240129 PERIOD START: 20240831 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Invesco Exchange-Traded Fund Trust II CENTRAL INDEX KEY: 0001378872 ORGANIZATION NAME: IRS NUMBER: 000000000 FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-21977 FILM NUMBER: 24570690 BUSINESS ADDRESS: STREET 1: 3500 LACEY ROAD STREET 2: SUITE 700 CITY: DOWNERS GROVE STATE: IL ZIP: 60515 BUSINESS PHONE: 800-983-0903 MAIL ADDRESS: STREET 1: 3500 LACEY ROAD STREET 2: SUITE 700 CITY: DOWNERS GROVE STATE: IL ZIP: 60515 FORMER COMPANY: FORMER CONFORMED NAME: PowerShares Exchange-Traded Fund Trust II DATE OF NAME CHANGE: 20070919 FORMER COMPANY: FORMER CONFORMED NAME: PowerShares Global Exchange-Traded Fund Trust DATE OF NAME CHANGE: 20061023 0001378872 S000077288 Invesco NASDAQ Future Gen 200 ETF C000237581 Invesco NASDAQ Future Gen 200 ETF QQQS NPORT-P 1 primary_doc.xml NPORT-P false 0001378872 XXXXXXXX S000077288 C000237581 Invesco Exchange-Traded Fund Trust II 811-21977 0001378872 O540V2L4S174Y60FMD36 3500 Lacey Road Suite 700 Downers Grove 60515 800-983-0903 Invesco NASDAQ Future Gen 200 ETF S000077288 549300GPI35ZCTF27915 2024-08-31 2023-11-30 N 7968518.19 2319302.29 5649215.90 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 N Avadel Pharmaceuticals PLC 549300E27PTSG2RHC762 Avadel Pharmaceuticals PLC, ADR 05337M104 2486.00000000 NS USD 28688.44000000 0.507830476084 Long EC CORP IE N 1 N N Soundhound AI, Inc. N/A Soundhound AI, Inc., Class A 836100107 13138.00000000 NS USD 28115.32000000 0.497685351342 Long EC CORP US N 1 N N Esperion Therapeutics, Inc. 549300OFU56UKEWVUS92 Esperion Therapeutics, Inc. 29664W105 20692.00000000 NS USD 27520.36000000 0.487153624275 Long EC CORP US N 1 N N I-Mab 549300L1A5T19703RR64 I-Mab, ADR 44975P103 17645.00000000 NS USD 27526.20000000 0.487257001453 Long EC CORP KY N 1 N N N GoPro, Inc. 549300CQJMLT21SZFL16 GoPro, Inc., Class A 38268T103 9246.00000000 NS USD 33378.06000000 0.590844120508 Long EC CORP US N 1 N N N Littelfuse, Inc. 549300MY7HLQFYTPCX75 Littelfuse, Inc. 537008104 126.00000000 NS USD 29332.80000000 0.519236660790 Long EC CORP US N 1 N N N MicroVision, Inc. 5299001A8NIHHA9KOY43 MicroVision, Inc. 594960304 13325.00000000 NS USD 33579.00000000 0.594401074315 Long EC CORP US N 1 N N OPKO Health, Inc. 529900A4S2D4OGOJLL02 OPKO Health, Inc. 68375N103 18371.00000000 NS USD 26821.66000000 0.474785536166 Long EC CORP US N 1 N N N OSI Systems, Inc. DDX3MPX1Y8YD30050X33 OSI Systems, Inc. 671044105 246.00000000 NS USD 30329.34000000 0.536876984998 Long EC CORP US N 1 N N Corcept Therapeutics Inc. 529900EO9LUTFMZ7FF90 Corcept Therapeutics Inc. 218352102 1027.00000000 NS USD 26157.69000000 0.463032223640 Long EC CORP US N 1 N N N Cartesian Therapeutics, Inc. 529900NMN0LACZOL7C43 Cartesian Therapeutics, Inc. 816212104 27325.00000000 NS USD 36888.75000000 0.652988851072 Long EC CORP US N 1 N N Goodyear Tire & Rubber Co. (The) 5493002BI0S2ZQUY3437 Goodyear Tire & Rubber Co. (The) 382550101 2599.00000000 NS USD 36100.11000000 0.639028683608 Long EC CORP US N 1 N N N Tactile Systems Technology, Inc. 54930069VDTITHOTKJ98 Tactile Systems Technology, Inc. 87357P100 1747.00000000 NS USD 23287.51000000 0.412225526731 Long EC CORP US N 1 N N Ligand Pharmaceuticals Inc. 5493008K7TB0IKP37H79 Ligand Pharmaceuticals Inc. 53220K504 510.00000000 NS USD 29738.10000000 0.526411107778 Long EC CORP US N 1 N N Quanterix Corp. N/A Quanterix Corp. 74766Q101 1254.00000000 NS USD 30058.38000000 0.532080567145 Long EC CORP US N 1 N N N Adaptive Biotechnologies Corp. 549300ZTF7OT1FW66Q96 Adaptive Biotechnologies Corp. 00650F109 4890.00000000 NS USD 21418.20000000 0.379135801837 Long EC CORP US N 1 N N CorMedix Inc. 5299006YIA3L0MBW8358 CorMedix Inc. 21900C308 8243.00000000 NS USD 26789.75000000 0.474220679014 Long EC CORP US N 1 N N Daktronics, Inc. 549300IOLZ3SG5YUJ288 Daktronics, Inc. 234264109 4008.00000000 NS USD 41803.44000000 0.739986588227 Long EC CORP US N 1 N N FARO Technologies, Inc. 529900MFEFNOFP3YR823 FARO Technologies, Inc. 311642102 2114.00000000 NS USD 38834.18000000 0.687426019600 Long EC CORP US N 1 N N LSI Industries Inc. 529900HY42OANH6BVT33 LSI Industries Inc. 50216C108 2131.00000000 NS USD 27937.41000000 0.494536064730 Long EC CORP US N 1 N N N Adaptimmune Therapeutics PLC 549300UUNWK8TRT5EW12 Adaptimmune Therapeutics PLC, ADR 00653A107 43060.00000000 NS USD 21530.00000000 0.381114837547 Long EC CORP GB N 1 N N N FibroGen, Inc. 549300Q914ULWWY95822 FibroGen, Inc. 31572Q808 34487.00000000 NS USD 19050.62000000 0.337225914838 Long EC CORP US N 1 N N Orthofix Medical Inc. N/A Orthofix Medical Inc. 68752M108 1565.00000000 NS USD 17293.25000000 0.306117703874 Long EC CORP US N 1 N N N Bicycle Therapeutics PLC 213800XKUI6R7GKC3E43 Bicycle Therapeutics PLC, ADR 088786108 1523.00000000 NS USD 21931.20000000 0.388216708092 Long EC CORP GB N 1 N N Matthews International Corp. 549300ZVC5O0ATML6U61 Matthews International Corp., Class A 577128101 795.00000000 NS USD 27149.25000000 0.480584394021 Long EC CORP US N 1 N N N Inovio Pharmaceuticals, Inc. 529900B9W875XDZXTM97 Inovio Pharmaceuticals, Inc. 45773H201 74554.00000000 NS USD 29389.19000000 0.520234852415 Long EC CORP US N 1 N N N Gevo, Inc. 549300IV6EW4O1OJD686 Gevo, Inc. 374396406 25596.00000000 NS USD 28923.48000000 0.511991053484 Long EC CORP US N 1 N N Alector, Inc. 549300Z8RQOIY1JMHC25 Alector, Inc. 014442107 6157.00000000 NS USD 33370.94000000 0.590718085318 Long EC CORP US N 1 N N InflaRx N.V. 391200708PAUDLQ31581 InflaRx N.V. N44821101 8382.00000000 NS USD 11315.70000000 0.200305674279 Long EC CORP NL N 1 N N N Karyopharm Therapeutics Inc. 549300J1VANRCNTYST87 Karyopharm Therapeutics Inc. 48576U106 25865.00000000 NS USD 19916.05000000 0.352545385988 Long EC CORP US N 1 N N N Immersion Corp. 529900AKNC1UAMQ2YB35 Immersion Corp. 452521107 4784.00000000 NS USD 31000.32000000 0.548754385542 Long EC CORP US N 1 N N N Ardelyx, Inc. 549300F542QR4SXHCY32 Ardelyx, Inc. 039697107 7886.00000000 NS USD 35565.86000000 0.629571618956 Long EC CORP US N 1 N N Rigel Pharmaceuticals, Inc. 529900KPTNUS5J8K9K66 Rigel Pharmaceuticals, Inc. 766559603 29493.00000000 NS USD 33622.02000000 0.595162595927 Long EC CORP US N 1 N N N Bel Fuse Inc. 2549009L4XYDBRRY6X39 Bel Fuse Inc., Class B 077347300 642.00000000 NS USD 34732.20000000 0.614814526738 Long EC CORP US N 1 N N N Accuray Inc. 549300G28LY4TZKZJG51 Accuray Inc. 004397105 11788.00000000 NS USD 30766.68000000 0.544618590342 Long EC CORP US N 1 N N N Mersana Therapeutics, Inc. 529900VWD5VDZ7PVOS22 Mersana Therapeutics, Inc. 59045L106 30224.00000000 NS USD 49869.60000000 0.882770297378 Long EC CORP US N 1 N N N Invesco Private Government Fund N/A Invesco Private Government Fund N/A 689285.51000000 NS USD 689285.51000000 12.20143684011 Long STIV PF US N 2 N N MacroGenics, Inc. 5493001KJQUA83L8MH79 MacroGenics, Inc. 556099109 7194.00000000 NS USD 59062.74000000 1.045503323744 Long EC CORP US N 1 N N Enanta Pharmaceuticals, Inc. 529900SSN4DODDQSN594 Enanta Pharmaceuticals, Inc. 29251M106 2229.00000000 NS USD 20818.86000000 0.368526541886 Long EC CORP US N 1 N N Innospec Inc. 213800SQBACNY5IWJO68 Innospec Inc. 45768S105 313.00000000 NS USD 32886.91000000 0.582149993594 Long EC CORP US N 1 N N N bluebird bio, Inc. N/A bluebird bio, Inc. 09609G100 8896.00000000 NS USD 33982.72000000 0.601547552820 Long EC CORP US N 1 N N MaxLinear, Inc. 549300EMOI0SM2IY4F64 MaxLinear, Inc. 57776J100 1409.00000000 NS USD 26390.57000000 0.467154565645 Long EC CORP US N 1 N N N Garrett Motion Inc. 549300LS5WT7EMBNV724 Garrett Motion Inc. 366505105 4327.00000000 NS USD 32019.80000000 0.566800783804 Long EC CORP US N 1 N N Roku, Inc. 549300KR6ITU0YIR1T71 Roku, Inc. 77543R102 413.00000000 NS USD 43034.60000000 0.761780055175 Long EC CORP US N 1 N N N Omeros Corp. 549300CJWLXX2MXVVV71 Omeros Corp. 682143102 9569.00000000 NS USD 20956.11000000 0.370956082595 Long EC CORP US N 1 N N Axogen, Inc. N/A Axogen, Inc. 05463X106 5289.00000000 NS USD 34642.95000000 0.613234661468 Long EC CORP US N 1 N N N NGM Biopharmaceuticals, Inc. 5493008V5DSDZIGQOP17 NGM Biopharmaceuticals, Inc. 62921N105 17517.00000000 NS USD 13083.45000000 0.231597627557 Long EC CORP US N 1 N N N Chimerix, Inc. 5299002IR2GXUBEPKS66 Chimerix, Inc. 16934W106 29469.00000000 NS USD 28661.55000000 0.507354480822 Long EC CORP US N 1 N N N MillerKnoll, Inc. U98HXD3PNK7HYU2MU887 MillerKnoll, Inc. 600544100 1756.00000000 NS USD 45304.80000000 0.801966163127 Long EC CORP US N 1 N N N Ironwood Pharmaceuticals, Inc. 549300PC8MR6QHH6P296 Ironwood Pharmaceuticals, Inc. 46333X108 3811.00000000 NS USD 37728.90000000 0.667860826490 Long EC CORP US N 1 N N N Turtle Beach Corp. 549300SZRV8U8PXSYI20 Turtle Beach Corp. 900450206 3089.00000000 NS USD 34936.59000000 0.618432550966 Long EC CORP US N 1 N N N Rambus Inc. 2549000211GDCQSLV833 Rambus Inc. 750917106 594.00000000 NS USD 40195.98000000 0.711532019868 Long EC CORP US N 1 N N Cara Therapeutics, Inc. 549300COVOY41P0GZ881 Cara Therapeutics, Inc. 140755109 12882.00000000 NS USD 12455.61000000 0.220483872814 Long EC CORP US N 1 N N N Ribbon Communications Inc. 549300L1E8Z8RL7CUL52 Ribbon Communications Inc. 762544104 11185.00000000 NS USD 23824.05000000 0.421723127983 Long EC CORP US N 1 N N N Xencor, Inc. 549300V5IF65437JKG30 Xencor, Inc. 98401F105 1526.00000000 NS USD 27986.84000000 0.495411053417 Long EC CORP US N 1 N N N Qurate Retail, Inc. 549300PSXEKU4PHLCR04 Qurate Retail, Inc., Class A 74915M100 43282.00000000 NS USD 33413.70000000 0.591475004522 Long EC CORP US N 1 N N N G1 Therapeutics, Inc. 529900TC35UPZQYRKW13 G1 Therapeutics, Inc. 3621LQ109 20107.00000000 NS USD 37801.16000000 0.669139942058 Long EC CORP US N 1 N N Cirrus Logic, Inc. 549300NKSJEM5ZZSSV18 Cirrus Logic, Inc. 172755100 409.00000000 NS USD 31047.19000000 0.549584058205 Long EC CORP US N 1 N N Haynes International, Inc. 549300I9MS5UZLRFDO40 Haynes International, Inc. 420877201 688.00000000 NS USD 33767.04000000 0.597729677847 Long EC CORP US N 1 N N N Sleep Number Corp. 529900W0TZQLBT2DSS66 Sleep Number Corp. 83125X103 1294.00000000 NS USD 13121.16000000 0.232265153824 Long EC CORP US N 1 N N N Agenus Inc. 529900NDQQGU5H4UJK81 Agenus Inc. 00847G705 23991.00000000 NS USD 18643.41000000 0.330017657848 Long EC CORP US N 1 N N N Gentherm Inc. HKM6YX1U5JS60TCUB219 Gentherm Inc. 37253A103 558.00000000 NS USD 25623.36000000 0.453573742862 Long EC CORP US N 1 N N N PDS Biotechnology Corp. 5493002KU8ACFTSMC935 PDS Biotechnology Corp. 70465T107 5720.00000000 NS USD 30087.20000000 0.532590726440 Long EC CORP US N 1 N N Apyx Medical Corp. 5299009QZVYUYO082S45 Apyx Medical Corp. 03837C106 7105.00000000 NS USD 16767.80000000 0.296816413053 Long EC CORP US N 1 N N N Merit Medical Systems, Inc. 549300OYTY138SP2CE83 Merit Medical Systems, Inc. 589889104 513.00000000 NS USD 36710.28000000 0.649829651580 Long EC CORP US N 1 N N N BRP Inc. 529900EPQGESIRCPY551 BRP Inc. 05577W200 440.00000000 NS USD 27161.20000000 0.480795927803 Long EC CORP CA N 1 N N N Geron Corp. 549300T282D7Z2YESL90 Geron Corp. 374163103 13827.00000000 NS USD 26686.11000000 0.472386088129 Long EC CORP US N 1 N N N Cerus Corp. 254900BIEY9XIDA04Q21 Cerus Corp. 157085101 17739.00000000 NS USD 28559.79000000 0.505553168891 Long EC CORP US N 1 N N Universal Display Corp. N/A Universal Display Corp. 91347P105 207.00000000 NS USD 35024.40000000 0.619986925973 Long EC CORP US N 1 N N Invesco Private Prime Fund N/A Invesco Private Prime Fund N/A 1629132.39240000 NS USD 1629132.39240000 28.83820376558 Long STIV PF US N 2 N N Newell Brands Inc. 549300LWGYFM1TVO1Z12 Newell Brands Inc. 651229106 3129.00000000 NS USD 23874.27000000 0.422612100911 Long EC CORP US N 1 N N N DENTSPLY SIRONA Inc. 9NHEHR1SOZCYXDO8HO28 DENTSPLY SIRONA Inc. 24906P109 906.00000000 NS USD 28765.50000000 0.509194559195 Long EC CORP US N 1 N N N OmniAb Operations, Inc. N/A OmniAb Operations, Inc., Rts., expiring 2027-11-02 68218J301 83.00000000 NS USD 0.00000000 0.000000 Long EC CORP US N 3 N N N Vaxart, Inc. N/A Vaxart, Inc. 92243A200 40771.00000000 NS USD 29151.27000000 0.516023294489 Long EC CORP US N 1 N N N Scilex Holding Co. N/A Scilex Holding Co., Class C 80880W106 2540.63000000 NS USD 3175.79000000 0.056216474219 Long EC CORP US N 1 N N N InterDigital, Inc. 529900HQAUTC3VI47G64 InterDigital, Inc. 45867G101 387.00000000 NS USD 38669.04000000 0.684502782058 Long EC CORP US N 1 N N N CommScope Holding Co., Inc. 254900AW4CEPCQWSRI58 CommScope Holding Co., Inc. 20337X109 9912.00000000 NS USD 16553.04000000 0.293014823526 Long EC CORP US N 1 N N N Nova Ltd. 529900B2DSWE5V3SC292 Nova Ltd. M7516K103 257.00000000 NS USD 33052.77000000 0.585085976267 Long EC CORP IL N 1 N N SI-BONE, Inc. 549300J8JGYVJJHV9C31 SI-BONE, Inc. 825704109 1468.00000000 NS USD 27833.28000000 0.492692800075 Long EC CORP US N 1 N N N OraSure Technologies, Inc. 529900GNNJPNM4XHXQ77 OraSure Technologies, Inc. 68554V108 5191.00000000 NS USD 37998.12000000 0.672626443609 Long EC CORP US N 1 N N N Bandwidth Inc. 549300QC70JB7MUGXM66 Bandwidth Inc., Class A 05988J103 2334.00000000 NS USD 25627.32000000 0.453643841085 Long EC CORP US N 1 N N N Verastem, Inc. 549300IY0EFBIU8NQC81 Verastem, Inc. 92337C203 3392.00000000 NS USD 23370.88000000 0.413701306760 Long EC CORP US N 1 N N N Gritstone bio, Inc. 5493003TER6KY3MUVY84 Gritstone bio, Inc. 39868T105 18423.00000000 NS USD 23949.90000000 0.423950870774 Long EC CORP US N 1 N N N GSI Technology, Inc. N/A GSI Technology, Inc. 36241U106 10799.00000000 NS USD 29913.23000000 0.529511184021 Long EC CORP US N 1 N N N nLight, Inc. N/A nLight, Inc. 65487K100 2942.00000000 NS USD 38893.24000000 0.688471474421 Long EC CORP US N 1 N N Hollysys Automation Technologies Ltd. 2549008FKCB1PSUOZ583 Hollysys Automation Technologies Ltd. G45667105 1778.00000000 NS USD 40538.40000000 0.717593392031 Long EC CORP VG N 1 N N N Eyenovia, Inc. N/A Eyenovia, Inc. 30234E104 17517.00000000 NS USD 24874.14000000 0.440311371353 Long EC CORP US N 1 N N N Axcelis Technologies, Inc. 529900HF9B6NL1QG9F05 Axcelis Technologies, Inc. 054540208 175.00000000 NS USD 21749.00000000 0.384991481738 Long EC CORP US N 1 N N SIGA Technologies, Inc. N/A SIGA Technologies, Inc. 826917106 7303.00000000 NS USD 39655.29000000 0.701960957094 Long EC CORP US N 1 N N X4 Pharmaceuticals, Inc. 549300R0UFVPXWP86U94 X4 Pharmaceuticals, Inc. 98420X103 25865.00000000 NS USD 20174.70000000 0.357123897495 Long EC CORP US N 1 N N N Theravance Biopharma, Inc. 5493007VTSXP4Z6MIW52 Theravance Biopharma, Inc. G8807B106 3524.00000000 NS USD 36931.52000000 0.653745947291 Long EC CORP KY N 1 N N Viavi Solutions Inc. 5493006K3E3N1QOBF092 Viavi Solutions Inc. 925550105 3214.00000000 NS USD 25969.12000000 0.459694238274 Long EC CORP US N 1 N N IGM Biosciences, Inc. 5493008XCQES2N0VY969 IGM Biosciences, Inc. 449585108 4702.00000000 NS USD 31691.48000000 0.560989003801 Long EC CORP US N 1 N N Synaptics Inc. 549300AJ3LI4FWNRQX29 Synaptics Inc. 87157D109 383.00000000 NS USD 38774.92000000 0.686377024464 Long EC CORP US N 1 N N N KalVista Pharmaceuticals, Inc. 529900Q7IDA3WUGRZA51 KalVista Pharmaceuticals, Inc. 483497103 3095.00000000 NS USD 26121.80000000 0.462396914233 Long EC CORP US N 1 N N SunPower Corp. 549300TXO070764WUH65 SunPower Corp. 867652406 4624.00000000 NS USD 19189.60000000 0.339686079266 Long EC CORP US N 1 N N N Autolus Therapeutics PLC 549300C0KZP8EYROLL02 Autolus Therapeutics PLC, ADR 05280R100 10436.00000000 NS USD 44666.08000000 0.790659815285 Long EC CORP GB N 1 N N N TPI Composites, Inc. 549300TI9H56OIY0QE39 TPI Composites, Inc. 87266J104 6556.00000000 NS USD 13833.16000000 0.244868672836 Long EC CORP US N 1 N N AtriCure, Inc. N/A AtriCure, Inc. 04963C209 743.00000000 NS USD 26361.64000000 0.466642459177 Long EC CORP US N 1 N N N Fossil Group, Inc. DDMY8YZ6L8UEMS1FDM73 Fossil Group, Inc. 34988V106 15829.00000000 NS USD 17411.90000000 0.308217995350 Long EC CORP US N 1 N N N Aclaris Therapeutics, Inc. 5493000B2LQ9QTW1DF52 Aclaris Therapeutics, Inc. 00461U105 4426.00000000 NS USD 3871.42000000 0.068530218503 Long EC CORP US N 1 N N N Workhorse Group Inc. 5493006JUAG258V8X854 Workhorse Group Inc. 98138J206 42641.00000000 NS USD 15849.66000000 0.280563892061 Long EC CORP US N 1 N N Pacific Biosciences of California, Inc. 529900F1BWRE1M0KZN89 Pacific Biosciences of California, Inc. 69404D108 2935.00000000 NS USD 24888.80000000 0.440570876393 Long EC CORP US N 1 N N Mitek Systems, Inc. 549300ABZAQ3R25XG118 Mitek Systems, Inc. 606710200 3007.00000000 NS USD 33949.03000000 0.600951186871 Long EC CORP US N 1 N N DISH Network Corp. 529900U350CWHH15G169 DISH Network Corp., Class A 25470M109 5518.00000000 NS USD 20195.88000000 0.357498816782 Long EC CORP US N 1 N N Agios Pharmaceuticals, Inc. 529900ONJHY8EOGYT555 Agios Pharmaceuticals, Inc. 00847X104 1224.00000000 NS USD 27209.52000000 0.481651267744 Long EC CORP US N 1 N N Veeco Instruments Inc. 5493004201F72ADDZW04 Veeco Instruments Inc. 922417100 1151.00000000 NS USD 32838.03000000 0.581284740772 Long EC CORP US N 1 N N Aviat Networks, Inc. 549300Z3X8Z4MK52CI65 Aviat Networks, Inc. 05366Y201 951.00000000 NS USD 28824.81000000 0.510244439409 Long EC CORP US N 1 N N N Universal Electronics Inc. 549300ZW9EULAR7T6F89 Universal Electronics Inc. 913483103 3767.00000000 NS USD 29344.93000000 0.519451380854 Long EC CORP US N 1 N N N Verint Systems Inc. 549300KEQJS5FRVUCO94 Verint Systems Inc. 92343X100 1022.00000000 NS USD 25110.54000000 0.444496022890 Long EC CORP US N 1 N N N Amarin Corp. PLC 5493009JFIGUFEVPK217 Amarin Corp. PLC, ADR 023111206 32029.00000000 NS USD 25046.68000000 0.443365600525 Long EC CORP GB N 1 N N N OmniAb Operations, Inc. 5493008K7TB0IKP37H79 OmniAb Operations, Inc., Rts., 2027-11-02 68218J202 83.00000000 NS USD 0.00000000 0.000000 Long EC CORP US N 3 N N N Dropbox, Inc. 549300JCDF7UAR6TJR51 Dropbox, Inc., Class A 26210C104 1209.00000000 NS USD 34069.62000000 0.603085819396 Long EC CORP US N 1 N N N Astronics Corp. 549300NNXCF8H4MSMK17 Astronics Corp. 046433108 1913.00000000 NS USD 28408.05000000 0.502867132410 Long EC CORP US N 1 N N N IPG Photonics Corp. 5493002KZ51CADQ94G15 IPG Photonics Corp. 44980X109 310.00000000 NS USD 29685.60000000 0.525481775267 Long EC CORP US N 1 N N Oramed Pharmaceuticals Inc. 5299006K52ZIIGQJ6R84 Oramed Pharmaceuticals Inc. 68403P203 10094.00000000 NS USD 22408.68000000 0.396668854521 Long EC CORP US N 1 N N N Bionano Genomics, Inc. 54930086AP7ROH0VJ631 Bionano Genomics, Inc. 09075F305 8577.00000000 NS USD 13637.43000000 0.241403944218 Long EC CORP US N 1 N N N Amicus Therapeutics, Inc. 549300MRD1SMUTNBPQ53 Amicus Therapeutics, Inc. 03152W109 2615.00000000 NS USD 28817.30000000 0.510111500606 Long EC CORP US N 1 N N N Stratasys Ltd. 529900MU215GIP9SZ741 Stratasys Ltd. M85548101 2286.00000000 NS USD 25237.44000000 0.446742352332 Long EC CORP IL N 1 N N Veradigm Inc. Y68YJHVB1GU4TAU3C223 Veradigm Inc. 01988P108 2509.00000000 NS USD 28803.32000000 0.509864032635 Long EC CORP US N 1 N N Power Integrations, Inc. 54930085LGXSCIHD5W31 Power Integrations, Inc. 739276103 399.00000000 NS USD 30487.59000000 0.539678258711 Long EC CORP US N 1 N N N Sangamo Therapeutics, Inc. 2549006WMRKRC4G32Z67 Sangamo Therapeutics, Inc. 800677106 34156.00000000 NS USD 14687.08000000 0.259984398896 Long EC CORP US N 1 N N N PTC Therapeutics, Inc. 549300UJLWOIWFDGB318 PTC Therapeutics, Inc. 69366J200 838.00000000 NS USD 19290.76000000 0.341476770254 Long EC CORP US N 1 N N LivaNova PLC 2138001K2FX6SHK2B339 LivaNova PLC G5509L101 604.00000000 NS USD 27089.40000000 0.479524954958 Long EC CORP GB N 1 N N Kodiak Sciences Inc. 254900IXI5NI8C9OQE24 Kodiak Sciences Inc. 50015M109 15266.00000000 NS USD 36943.72000000 0.653961906465 Long EC CORP US N 1 N N N AeroVironment, Inc. 529900PGHVI29YLZ6221 AeroVironment, Inc. 008073108 346.00000000 NS USD 47613.06000000 0.842825992895 Long EC CORP US N 1 N N Semtech Corp. 549300J7WUY317SW6O61 Semtech Corp. 816850101 1266.00000000 NS USD 20724.42000000 0.366854805460 Long EC CORP US N 1 N N uniQure N.V. 724500RPCTZLFYJZ3S98 uniQure N.V. N90064101 3801.00000000 NS USD 25770.78000000 0.456183308554 Long EC CORP NL N 1 N N N Gentex Corp. 549300S3UD8XV1MN0287 Gentex Corp. 371901109 1027.00000000 NS USD 31231.07000000 0.552839023199 Long EC CORP US N 1 N N N Galera Therapeutics, Inc. N/A Galera Therapeutics, Inc. 36338D108 157653.00000000 NS USD 22465.55000000 0.397675542901 Long EC CORP US N 1 N N N ImmunoGen, Inc. 54930084U0R1OP766Y02 ImmunoGen, Inc. 45253H101 2118.00000000 NS USD 62163.30000000 1.100388108728 Long EC CORP US N 1 N N Lexicon Pharmaceuticals, Inc. N/A Lexicon Pharmaceuticals, Inc. 528872302 19550.00000000 NS USD 20723.00000000 0.366829669228 Long EC CORP US N 1 N N Heron Therapeutics, Inc. 549300DR2I1DOPD2IX53 Heron Therapeutics, Inc. 427746102 20187.00000000 NS USD 24830.01000000 0.439530200996 Long EC CORP US N 1 N N Ocugen, Inc. 549300JVNUI9CXWJLR09 Ocugen, Inc. 67577C105 77789.00000000 NS USD 30081.01000000 0.532481153711 Long EC CORP US N 1 N N N Arbutus Biopharma Corp. 25490064CESONAUIAS23 Arbutus Biopharma Corp. 03879J100 16524.00000000 NS USD 33874.20000000 0.599626578265 Long EC CORP CA N 1 N N AngioDynamics, Inc. 549300W3VKC5ZKMO8C28 AngioDynamics, Inc. 03475V101 4180.00000000 NS USD 27295.40000000 0.483171478717 Long EC CORP US N 1 N N N Omnicell, Inc. 5493008RH0GTKHHPZI77 Omnicell, Inc. 68213N109 582.00000000 NS USD 19415.52000000 0.343685218332 Long EC CORP US N 1 N N N Aehr Test Systems 529900A4GWWZFRU2RE97 Aehr Test Systems 00760J108 649.00000000 NS USD 14901.04000000 0.263771827166 Long EC CORP US N 1 N N Ionis Pharmaceuticals, Inc. 549300SI4ZGLG0BLUZ92 Ionis Pharmaceuticals, Inc. 462222100 834.00000000 NS USD 41257.98000000 0.730331088956 Long EC CORP US N 1 N N Anika Therapeutics, Inc. 529900R9LS3Z0O6QH455 Anika Therapeutics, Inc. 035255108 1877.00000000 NS USD 41125.07000000 0.727978373069 Long EC CORP US N 1 N N N Itron, Inc. 24F6LSZD18II6ICG6S41 Itron, Inc. 465741106 491.00000000 NS USD 33083.58000000 0.585631361690 Long EC CORP US N 1 N N Luna Innovations Inc. N/A Luna Innovations Inc. 550351100 4866.00000000 NS USD 30996.42000000 0.548685349412 Long EC CORP US N 1 N N EchoStar Corp. 549300EE20907QZ9GT38 EchoStar Corp., Class A 278768106 1905.00000000 NS USD 19945.35000000 0.353064042038 Long EC CORP US N 1 N N Vuzix Corp. 549300EWPW64TZQXJG66 Vuzix Corp. 92921W300 8390.00000000 NS USD 17619.00000000 0.311883990838 Long EC CORP US N 1 N N Purple Innovation, Inc. N/A Purple Innovation, Inc. 74640Y106 15257.00000000 NS USD 9465.44000000 0.167553164324 Long EC CORP US N 1 N N Phibro Animal Health Corp. 549300U24SP4AF2JUX52 Phibro Animal Health Corp., Class A 71742Q106 2404.00000000 NS USD 23054.36000000 0.408098405302 Long EC CORP US N 1 N N N Azenta, Inc. 35ZN6X1ANPH25YN32Y17 Azenta, Inc. 114340102 595.00000000 NS USD 33540.15000000 0.593713368257 Long EC CORP US N 1 N N N Innoviva, Inc. 549300ACOX4QTBES6535 Innoviva, Inc. 45781M101 2630.00000000 NS USD 36425.50000000 0.644788598007 Long EC CORP US N 1 N N Coherus BioSciences, Inc. 5493007IL8W5MV932D26 Coherus BioSciences, Inc. 19249H103 6211.00000000 NS USD 13229.43000000 0.234181702986 Long EC CORP US N 1 N N MannKind Corp. 213800GFBCNY1ZFST722 MannKind Corp. 56400P706 7282.00000000 NS USD 26360.84000000 0.466628297920 Long EC CORP US N 1 N N Eagle Pharmaceuticals, Inc. 549300TN20OLYTJVP152 Eagle Pharmaceuticals, Inc. 269796108 1980.00000000 NS USD 11583.00000000 0.205037304380 Long EC CORP US N 1 N N N Akebia Therapeutics, Inc. 549300CBQEHMKEEGNX42 Akebia Therapeutics, Inc. 00972D105 24186.00000000 NS USD 25637.16000000 0.453818024550 Long EC CORP US N 1 N N Altimmune, Inc. 549300EOYCQ8SW3NVE64 Altimmune, Inc. 02155H200 13261.00000000 NS USD 41904.76000000 0.741780111466 Long EC CORP US N 1 N N N BioCryst Pharmaceuticals, Inc. 549300Z0INP1Z5NP6J59 BioCryst Pharmaceuticals, Inc. 09058V103 4719.00000000 NS USD 27747.72000000 0.491178253605 Long EC CORP US N 1 N N Helen of Troy Ltd. N/A Helen of Troy Ltd. G4388N106 274.00000000 NS USD 28778.22000000 0.509419723186 Long EC CORP BM N 1 N N AnaptysBio, Inc. 529900HH4WQT03IG1A12 AnaptysBio, Inc. 032724106 1704.00000000 NS USD 24094.56000000 0.426511580129 Long EC CORP US N 1 N N Comtech Telecommunications Corp. 529900FTEZ8MGM0Y8F73 Comtech Telecommunications Corp. 205826209 3337.00000000 NS USD 39409.97000000 0.697618407538 Long EC CORP US N 1 N N N Integra LifeSciences Holdings Corp. WB7IJCYY8YFTENS4O147 Integra LifeSciences Holdings Corp. 457985208 790.00000000 NS USD 30960.10000000 0.548042428330 Long EC CORP US N 1 N N N Twist Bioscience Corp. 549300T23BL59LCOH584 Twist Bioscience Corp. 90184D100 1528.00000000 NS USD 36748.40000000 0.650504435491 Long EC CORP US N 1 N N CytomX Therapeutics, Inc. 5493004VW2FW0QLL3345 CytomX Therapeutics, Inc. 23284F105 22364.00000000 NS USD 31085.96000000 0.550270348138 Long EC CORP US N 1 N N Silicon Laboratories Inc. 4PRDF8Q9TDHRVZKZSZ47 Silicon Laboratories Inc. 826919102 247.00000000 NS USD 26026.39000000 0.460708007282 Long EC CORP US N 1 N N N Corvus Pharmaceuticals, Inc. 549300I3AVJ8F75NCX65 Corvus Pharmaceuticals, Inc. 221015100 15617.00000000 NS USD 23894.01000000 0.422961529935 Long EC CORP US N 1 N N N Arrowhead Pharmaceuticals, Inc. 549300O3CSB8T7OZ3D66 Arrowhead Pharmaceuticals, Inc. 04280A100 1215.00000000 NS USD 25758.00000000 0.455957082468 Long EC CORP US N 1 N N Ballard Power Systems Inc. 549300OHZ8BMF53YYS26 Ballard Power Systems Inc. 058586108 7996.00000000 NS USD 28065.96000000 0.496811601765 Long EC CORP CA N 1 N N Invesco Government & Agency Portfolio 5493007T1J7WZ5QI1A47 Invesco Government & Agency Portfolio, Institutional Class 825252885 3041.68000000 NS USD 3041.68000000 0.053842516445 Long STIV RF US N 1 N N N Kimball Electronics, Inc. 549300COBYN2GZCBIU87 Kimball Electronics, Inc. 49428J109 1112.00000000 NS USD 27399.68000000 0.485017398609 Long EC CORP US N 1 N N Netgear, Inc. 54930067KX3UNRHDWA78 Netgear, Inc. 64111Q104 2547.00000000 NS USD 34741.08000000 0.614971716694 Long EC CORP US N 1 N N N Wave Life Sciences Ltd. 54930070006GPKFYZ813 Wave Life Sciences Ltd. Y95308105 7712.00000000 NS USD 40950.72000000 0.724892104052 Long EC CORP SG N 1 N N N Sonos, Inc. 549300WEPU6075I77M08 Sonos, Inc. 83570H108 2439.00000000 NS USD 36828.90000000 0.651929412009 Long EC CORP US N 1 N N Kulicke and Soffa Industries, Inc. 529900H6BEIRBF429744 Kulicke and Soffa Industries, Inc. 501242101 648.00000000 NS USD 33384.96000000 0.590966261353 Long EC CORP US N 1 N N Codexis, Inc. N/A Codexis, Inc. 192005106 19291.00000000 NS USD 45526.76000000 0.805895203969 Long EC CORP US N 1 N N N 8x8, Inc. 254900XWSOC5U1BRW939 8x8, Inc. 282914100 10337.00000000 NS USD 31941.33000000 0.565411741477 Long EC CORP US N 1 N N Supernus Pharmaceuticals, Inc. 549300GRM36VBKISYJ58 Supernus Pharmaceuticals, Inc. 868459108 1046.00000000 NS USD 28503.50000000 0.504556747424 Long EC CORP US N 1 N N Cidara Therapeutics, Inc. 549300IHQ9Z7RI1X2D22 Cidara Therapeutics, Inc. 171757107 42790.00000000 NS USD 30355.23000000 0.537335278688 Long EC CORP US N 1 N N N Nektar Therapeutics 5299005I24806IOIYE03 Nektar Therapeutics 640268108 56359.00000000 NS USD 27615.91000000 0.488845009446 Long EC CORP US N 1 N N N Sutro Biopharma, Inc. 5493005U6P15VD25P851 Sutro Biopharma, Inc. 869367102 6970.00000000 NS USD 18191.70000000 0.322021680920 Long EC CORP US N 1 N N N Surmodics, Inc. 549300H76KXCAAGUS878 Surmodics, Inc. 868873100 911.00000000 NS USD 29899.02000000 0.529259644688 Long EC CORP US N 1 N N N ICU Medical, Inc. 5493003NRW7LS2QZRH60 ICU Medical, Inc. 44930G107 228.00000000 NS USD 20009.28000000 0.354195703513 Long EC CORP US N 1 N N MKS Instruments, Inc. 549300KEQATBHAGVF505 MKS Instruments, Inc. 55306N104 336.00000000 NS USD 27736.80000000 0.490984952442 Long EC CORP US N 1 N N N Atomera Inc. N/A Atomera Inc. 04965B100 5279.00000000 NS USD 36372.31000000 0.643847051411 Long EC CORP US N 1 N N Himax Technologies, Inc. 529900Z6XWS79D8T1X09 Himax Technologies, Inc., ADR 43289P106 5487.00000000 NS USD 31330.77000000 0.554603869892 Long EC CORP KY N 1 N N Varex Imaging Corp. 549300CWYWPVCT8E9W67 Varex Imaging Corp. 92214X106 1707.00000000 NS USD 32176.95000000 0.569582585788 Long EC CORP US N 1 N N Viasat, Inc. UFC8NYMNFSYIHNSM2I38 Viasat, Inc. 92552V100 1193.00000000 NS USD 24396.85000000 0.431862588222 Long EC CORP US N 1 N N Alpha and Omega Semiconductor Ltd. 5493001FE7J03YOV2V35 Alpha and Omega Semiconductor Ltd. G6331P104 1065.00000000 NS USD 22780.35000000 0.403247997655 Long EC CORP BM N 1 N N N Editas Medicine, Inc. 5299000AON4Q9NT2JE42 Editas Medicine, Inc. 28106W103 3771.00000000 NS USD 39708.63000000 0.702905158926 Long EC CORP US N 1 N N Mural Oncology PLC N/A Mural Oncology PLC G63365103 114.00000000 NS USD 411.54000000 0.007284904795 Long EC CORP IE N 1 N N N Lumentum Holdings Inc. 549300JLWRRC38DWEF52 Lumentum Holdings Inc. 55024U109 621.00000000 NS USD 26578.80000000 0.470486532476 Long EC CORP US N 1 N N N LivePerson, Inc. 549300IN2P1JZ20G7N40 LivePerson, Inc. 538146101 7883.00000000 NS USD 22387.72000000 0.396297829580 Long EC CORP US N 1 N N N NanoString Technologies, Inc. 549300G4CK0Y3WRDMY89 NanoString Technologies, Inc. 63009R109 12932.00000000 NS USD 6431.08000000 0.113840223383 Long EC CORP US N 1 N N N Alphatec Holdings, Inc. 549300EZE8CQ8K65FS24 Alphatec Holdings, Inc. 02081G201 2025.00000000 NS USD 24036.75000000 0.425488252272 Long EC CORP US N 1 N N N Infinera Corp. 549300ZOF66WPV3H0H17 Infinera Corp. 45667G103 7073.00000000 NS USD 27513.97000000 0.487040511232 Long EC CORP US N 1 N N Extreme Networks, Inc. 549300WRECW11X94UB57 Extreme Networks, Inc. 30226D106 1206.00000000 NS USD 19464.84000000 0.344558259846 Long EC CORP US N 1 N N N Seres Therapeutics, Inc. 549300GMXBE5NUWISF13 Seres Therapeutics, Inc. 81750R102 9596.00000000 NS USD 9979.84000000 0.176658852779 Long EC CORP US N 1 N N MiMedx Group, Inc. N/A MiMedx Group, Inc. 602496101 4518.00000000 NS USD 35104.86000000 0.621411194427 Long EC CORP US N 1 N N N Alkermes PLC 549300YHRMYLL071E243 Alkermes PLC G01767105 1149.00000000 NS USD 27736.86000000 0.490986014536 Long EC CORP IE N 1 N N N Merus N.V. 549300W8GPUWU8QNU293 Merus N.V. N5749R100 1499.00000000 NS USD 37085.26000000 0.656467386916 Long EC CORP NL N 1 N N N Vanda Pharmaceuticals Inc. 529900AY8VOOQBKJ0O70 Vanda Pharmaceuticals Inc. 921659108 6464.00000000 NS USD 24046.08000000 0.425653407935 Long EC CORP US N 1 N N N Voyager Therapeutics, Inc. 54930082S4XVR0ZWCC74 Voyager Therapeutics, Inc. 92915B106 3304.00000000 NS USD 23987.04000000 0.424608307145 Long EC CORP US N 1 N N N Interface, Inc. 549300VXZWQOIDFPU355 Interface, Inc. 458665304 3246.00000000 NS USD 32817.06000000 0.580913538815 Long EC CORP US N 1 N N N Amkor Technology, Inc. 529900VHLRTKPWZJBM84 Amkor Technology, Inc. 031652100 1200.00000000 NS USD 33804.00000000 0.598383927935 Long EC CORP US N 1 N N N Digimarc Corp. 254900TL728B5T0M5R41 Digimarc Corp. 25381B101 1026.00000000 NS USD 34258.14000000 0.606422919683 Long EC CORP US N 1 N N Fate Therapeutics, Inc. 549300L14Q4UHOODLA90 Fate Therapeutics, Inc. 31189P102 13378.00000000 NS USD 33311.22000000 0.589660947459 Long EC CORP US N 1 N N ProQR Therapeutics N.V. 549300NGS2FJGGDBGS06 ProQR Therapeutics N.V. N71542109 21124.00000000 NS USD 32742.20000000 0.579588399161 Long EC CORP NL N 1 N N N Commvault Systems, Inc. 65T5VRP62VXG39YFML83 Commvault Systems, Inc. 204166102 492.00000000 NS USD 36201.36000000 0.640820967738 Long EC CORP US N 1 N N N 2023-12-30 Invesco Exchange-Traded Fund Trust II Adrien Deberghes Adrien Deberghes Vice President XXXX NPORT-EX 2 edgar.htm
Schedule of Investments(a)
Invesco ESG NASDAQ 100 ETF (QQMG)
November 30, 2023
(Unaudited)
  Shares   Value
Common Stocks & Other Equity Interests-99.88%
Communication Services-11.67%
Alphabet, Inc., Class A(b)
  4,062   $538,337
Alphabet, Inc., Class C(b)
  3,971   531,796
Charter Communications, Inc., Class A(b)
  211   84,427
Comcast Corp., Class A
  6,473   271,154
Electronic Arts, Inc.
  673   92,881
Meta Platforms, Inc., Class A(b)
  800   261,720
Netflix, Inc.(b)
  973   461,173
Sirius XM Holdings, Inc.(c)
  8,619   40,337
T-Mobile US, Inc.
  1,680   252,756
Trade Desk, Inc. (The), Class A(b)
  730   51,436
Warner Bros Discovery, Inc.(b)
  4,528   47,317
        2,633,334
Consumer Discretionary-10.36%
Airbnb, Inc., Class A(b)(c)
  680   85,911
Amazon.com, Inc.(b)
  4,237   618,983
Booking Holdings, Inc.(b)
  69   215,673
eBay, Inc.
  1,109   45,480
JD.com, Inc., ADR (China)(c)
  618   16,952
Lucid Group, Inc.(b)(c)
  4,056   17,116
lululemon athletica, inc.(b)(c)
  259   115,721
Marriott International, Inc., Class A
  515   104,391
MercadoLibre, Inc. (Brazil)(b)
  79   128,017
O’Reilly Automotive, Inc., Class R(b)
  156   153,251
PDD Holdings, Inc., ADR (China)(b)
  653   96,278
Ross Stores, Inc.
  690   89,962
Starbucks Corp.
  1,635   162,356
Tesla, Inc.(b)
  2,032   487,843
        2,337,934
Consumer Staples-5.95%
Costco Wholesale Corp.
  678   401,878
Dollar Tree, Inc.(b)
  513   63,402
Keurig Dr Pepper, Inc.
  2,182   68,886
Kraft Heinz Co. (The)
  671   23,559
Mondelez International, Inc., Class A
  2,276   161,732
Monster Beverage Corp.(b)
  1,050   57,907
PepsiCo, Inc.
  3,138   528,094
Walgreens Boots Alliance, Inc.
  1,907   38,026
        1,343,484
Financials-0.58%
PayPal Holdings, Inc.(b)
  2,271   130,832
Health Care-5.96%
Align Technology, Inc.(b)
  144   30,787
Amgen, Inc.
  898   242,137
AstraZeneca PLC, ADR (United Kingdom)
  948   61,231
Biogen, Inc.(b)
  239   55,945
DexCom, Inc.(b)
  588   67,926
Gilead Sciences, Inc.
  1,987   152,204
IDEXX Laboratories, Inc.(b)
  165   76,860
Illumina, Inc.(b)
  427   43,533
Intuitive Surgical, Inc.(b)
  619   192,410
Moderna, Inc.(b)(c)
  597   46,387
Regeneron Pharmaceuticals, Inc.(b)
  216   177,943
Seagen, Inc.(b)(c)
  232   49,465
Vertex Pharmaceuticals, Inc.(b)
  415   147,246
        1,344,074
Industrials-4.07%
Automatic Data Processing, Inc.
  1,004   230,840
Cintas Corp.
  206   113,970
  Shares   Value
Industrials-(continued)
Copart, Inc.(b)
  2,129   $106,918
CSX Corp.
  3,377   109,077
Fastenal Co.
  815   48,876
Old Dominion Freight Line, Inc.
  237   92,207
PACCAR, Inc.
  601   55,184
Paychex, Inc.
  784   95,624
Verisk Analytics, Inc.
  273   65,910
        918,606
Information Technology-60.77%
Adobe, Inc.(b)
  1,141   697,162
Advanced Micro Devices, Inc.(b)
  3,703   448,655
ANSYS, Inc.(b)
  192   56,325
Apple, Inc.
  15,451   2,934,917
Applied Materials, Inc.
  2,122   317,833
ASML Holding N.V., New York Shares (Netherlands)
  245   167,521
Atlassian Corp., Class A(b)
  280   53,466
Autodesk, Inc.(b)
  471   102,881
Broadcom, Inc.
  769   711,886
Cadence Design Systems, Inc.(b)
  707   193,202
Cisco Systems, Inc.
  10,494   507,700
Cognizant Technology Solutions Corp., Class A
  1,194   84,034
CrowdStrike Holdings, Inc., Class A(b)
  348   82,473
Datadog, Inc., Class A(b)
  648   75,537
Enphase Energy, Inc.(b)(c)
  232   23,437
Fortinet, Inc.(b)
  1,542   81,048
GLOBALFOUNDRIES, Inc.(b)(c)
  1,242   66,683
Intel Corp.
  8,232   367,970
Intuit, Inc.
  615   351,448
KLA Corp.
  290   157,940
Lam Research Corp.
  325   232,674
Marvell Technology, Inc.
  1,810   100,871
Microchip Technology, Inc.
  414   34,544
Micron Technology, Inc.
  2,223   169,215
Microsoft Corp.
  7,953   3,013,471
NVIDIA Corp.
  2,827   1,322,188
NXP Semiconductors N.V. (China)
  484   98,775
ON Semiconductor Corp.(b)
  705   50,288
Palo Alto Networks, Inc.(b)(c)
  742   218,957
QUALCOMM, Inc.
  2,583   333,336
Synopsys, Inc.(b)
  375   203,711
Texas Instruments, Inc.
  1,639   250,292
Workday, Inc., Class A(b)
  439   118,846
Zoom Video Communications, Inc., Class A(b)
  489   33,169
Zscaler, Inc.(b)
  258   50,963
        13,713,418
Real Estate-0.25%
CoStar Group, Inc.(b)
  687   57,049
Utilities-0.27%
Exelon Corp.
  1,587   61,115
Total Common Stocks & Other Equity Interests

(Cost $21,333,917)
  22,539,846
See accompanying notes which are an integral part of this schedule.
Invesco ESG NASDAQ 100 ETF (QQMG)—(continued)
November 30, 2023
(Unaudited)
  Shares   Value
Money Market Funds-0.04%
Invesco Government & Agency Portfolio, Institutional Class, 5.28%(d)(e)

(Cost $9,152)
  9,152   $9,152
TOTAL INVESTMENTS IN SECURITIES

(excluding investments purchased with cash collateral from securities on loan)-99.92%

(Cost $21,343,069)
  22,548,998
Investments Purchased with Cash Collateral from Securities on Loan
Money Market Funds-3.02%
Invesco Private Government Fund, 5.32%(d)(e)(f)
  191,120   191,120
  Shares   Value
Money Market Funds-(continued)
Invesco Private Prime Fund, 5.55%(d)(e)(f)
  491,116   $491,312
Total Investments Purchased with Cash Collateral from Securities on Loan

(Cost $682,362)
  682,432
TOTAL INVESTMENTS IN SECURITIES-102.94%

(Cost $22,025,431)
  23,231,430
OTHER ASSETS LESS LIABILITIES-(2.94)%
  (664,069)
NET ASSETS-100.00%
  $22,567,361
 
Investment Abbreviations:
ADR -American Depositary Receipt
    
Notes to Schedule of Investments:
(a) Industry and/or sector classifications used in this report are generally according to the Global Industry Classification Standard, which was developed by and is the exclusive property and a service mark of MSCI Inc. and Standard & Poor’s.
(b) Non-income producing security.
(c) All or a portion of this security was out on loan at November 30, 2023.
(d) Affiliated holding. Affiliated holdings are investments in entities which are under common ownership or control of Invesco Ltd. or are investments in entities in which the Fund owns 5% or more of the outstanding voting securities. The table below shows the Fund’s transactions in, and earnings from, its investments in affiliates for the three months ended November 30, 2023.
    
  Value
August 31, 2023 		  Purchases
at Cost 		  Proceeds
from Sales 		  Change in
Unrealized
Appreciation 		  Realized
Gain 		  Value
November 30, 2023 		  Dividend
Income
Investments in Affiliated Money Market Funds:                          
Invesco Government & Agency Portfolio, Institutional Class $-   $26,151   $(16,999)   $-   $-   $9,152   $54
Investments Purchased with Cash Collateral from Securities on Loan:                          
Invesco Private Government Fund 857,889   718,662   (1,385,431)   -   -   191,120   4,773*
Invesco Private Prime Fund 2,404,298   1,539,594   (3,452,819)   80   159   491,312   12,765*
Total $3,262,187   $2,284,407   $(4,855,249)   $80   $159   $691,584   $17,592
    
* Represents the income earned on the investment of cash collateral. Does not include rebates and fees paid to lending agent or premiums received from borrowers, if any.
    
(e) The rate shown is the 7-day SEC standardized yield as of November 30, 2023.
(f) The security has been segregated to satisfy the commitment to return the cash collateral received in securities lending transactions upon the borrower’s return of the securities loaned.  
The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.
See accompanying notes which are an integral part of this schedule.
Schedule of Investments(a)
Invesco ESG NASDAQ Next Gen 100 ETF (QQJG)
November 30, 2023
(Unaudited)
  Shares   Value
Common Stocks & Other Equity Interests-99.92%
Communication Services-10.63%
Fox Corp., Class A(b)
  975   $28,801
Fox Corp., Class B
  905   25,032
Liberty Broadband Corp., Class A(c)
  47   3,898
Liberty Broadband Corp., Class C(c)
  322   26,765
Liberty Global Ltd., Class A (Bermuda)(c)
  408   6,528
Liberty Global Ltd., Class C (Bermuda)(b)(c)
  502   8,454
Liberty Media Corp.-Liberty Formula One(c)
  615   39,151
Match Group, Inc.(c)
  854   27,653
News Corp., Class A(b)
  1,545   34,052
News Corp., Class B(b)
  780   17,971
Paramount Global, Class B(b)
  2,185   31,398
Take-Two Interactive Software, Inc.(c)
  599   94,762
ZoomInfo Technologies, Inc., Class A(b)(c)
  952   13,680
        358,145
Consumer Discretionary-11.79%
Etsy, Inc.(c)
  323   24,486
Expedia Group, Inc.(c)
  244   33,228
Five Below, Inc.(b)(c)
  171   32,227
Hasbro, Inc.(b)
  651   30,213
LKQ Corp.
  1,109   49,384
Pool Corp.
  153   53,140
Tractor Supply Co.
  372   75,520
Trip.com Group Ltd., ADR (China)(b)(c)
  727   25,576
Ulta Beauty, Inc.(c)
  172   73,270
        397,044
Consumer Staples-3.07%
Coca-Cola Europacific Partners PLC (United Kingdom)
  1,704   103,330
Financials-1.05%
Jack Henry & Associates, Inc.
  223   35,388
Health Care-18.11%
Acadia Healthcare Co., Inc.(c)
  147   10,730
Alnylam Pharmaceuticals, Inc.(c)
  207   34,828
Argenx SE, ADR (Netherlands)(c)
  33   14,870
BeiGene Ltd., ADR (China)(b)(c)
  77   14,394
BioMarin Pharmaceutical, Inc.(c)
  385   35,066
BioNTech SE, ADR (Germany)(c)
  213   21,387
Bio-Techne Corp.
  511   32,142
Bruker Corp.
  405   26,361
Henry Schein, Inc.(c)
  487   32,497
Hologic, Inc.(c)
  526   37,504
ICON PLC(c)
  348   92,895
Incyte Corp.(c)
  489   26,572
Insulet Corp.(b)(c)
  151   28,553
Jazz Pharmaceuticals PLC(b)(c)
  124   14,661
Karuna Therapeutics, Inc.(b)(c)
  36   6,884
Neurocrine Biosciences, Inc.(c)
  212   24,717
Novocure Ltd.(b)(c)
  150   1,840
R1 RCM, Inc.(b)(c)
  964   10,199
Repligen Corp.(b)(c)
  188   29,563
Royalty Pharma PLC, Class A
  695   18,814
Sanofi S.A., ADR
  749   35,016
Sarepta Therapeutics, Inc.(b)(c)
  95   7,722
Shockwave Medical, Inc.(b)(c)
  53   9,251
United Therapeutics Corp.(c)
  117   28,080
Viatris, Inc.
  1,680   15,422
        609,968
Industrials-10.10%
American Airlines Group, Inc.(b)(c)
  1,276   15,861
  Shares   Value
Industrials-(continued)
Avis Budget Group, Inc.(c)
  148   $27,062
C.H. Robinson Worldwide, Inc.
  344   28,225
Grab Holdings Ltd., Class A (Singapore)(b)(c)
  9,016   27,408
J.B. Hunt Transport Services, Inc.
  373   69,106
Lincoln Electric Holdings, Inc.(b)
  149   29,511
Middleby Corp. (The)(b)(c)
  74   9,341
Nordson Corp.
  123   28,947
Paylocity Holding Corp.(c)
  149   23,344
SS&C Technologies Holdings, Inc.
  609   34,262
Tetra Tech, Inc.
  165   26,095
United Airlines Holdings, Inc.(c)
  535   21,079
        340,241
Information Technology-44.59%
Akamai Technologies, Inc.(b)(c)
  499   57,649
Amdocs Ltd.
  468   39,204
Bentley Systems, Inc., Class B
  965   50,238
CDW Corp.
  591   124,630
Check Point Software Technologies Ltd. (Israel)(c)
  284   41,464
Cognex Corp.
  689   25,975
DocuSign, Inc.(b)(c)
  617   26,593
Entegris, Inc.
  429   44,788
F5, Inc.(c)
  194   33,211
First Solar, Inc.(c)
  332   52,383
Flex Ltd.(c)
  2,150   54,718
Gen Digital, Inc.
  2,112   46,633
Logitech International S.A., Class R (Switzerland)(b)
  613   53,760
Manhattan Associates, Inc.(c)
  197   43,941
MongoDB, Inc.(c)
  220   91,463
Monolithic Power Systems, Inc.
  132   72,431
NetApp, Inc.
  737   67,354
Okta, Inc.(c)
  501   33,592
Open Text Corp. (Canada)
  869   34,882
PTC, Inc.(c)
  359   56,492
Qorvo, Inc.(c)
  161   15,537
Seagate Technology Holdings PLC
  816   64,546
Skyworks Solutions, Inc.
  275   26,656
SolarEdge Technologies, Inc.(b)(c)
  195   15,479
Splunk, Inc.(b)(c)
  434   65,768
Teradyne, Inc.(b)
  506   46,668
Trimble, Inc.(c)
  981   45,518
VeriSign, Inc.(c)
  274   58,143
Western Digital Corp.(b)(c)
  1,316   63,576
Zebra Technologies Corp., Class A(c)
  205   48,581
        1,501,873
Materials-0.58%
Steel Dynamics, Inc.
  166   19,775
TOTAL INVESTMENTS IN SECURITIES

(excluding investments purchased with cash collateral from securities on loan)-99.92%

(Cost $3,627,476)
  3,365,764
Investments Purchased with Cash Collateral from Securities on Loan
Money Market Funds-20.49%
Invesco Private Government Fund, 5.32%(d)(e)(f)
  193,233   193,233
See accompanying notes which are an integral part of this schedule.
Invesco ESG NASDAQ Next Gen 100 ETF (QQJG)—(continued)
November 30, 2023
(Unaudited)
  Shares   Value
Money Market Funds-(continued)
Invesco Private Prime Fund, 5.55%(d)(e)(f)
  496,568   $496,767
Total Investments Purchased with Cash Collateral from Securities on Loan

(Cost $689,939)
  690,000
TOTAL INVESTMENTS IN SECURITIES-120.41%

(Cost $4,317,415)
  4,055,764
OTHER ASSETS LESS LIABILITIES-(20.41)%
  (687,385)
NET ASSETS-100.00%
  $3,368,379
Investment Abbreviations:
ADR -American Depositary Receipt
    
Notes to Schedule of Investments:
(a) Industry and/or sector classifications used in this report are generally according to the Global Industry Classification Standard, which was developed by and is the exclusive property and a service mark of MSCI Inc. and Standard & Poor’s.
(b) All or a portion of this security was out on loan at November 30, 2023.
(c) Non-income producing security.
(d) Affiliated holding. Affiliated holdings are investments in entities which are under common ownership or control of Invesco Ltd. or are investments in entities in which the Fund owns 5% or more of the outstanding voting securities. The table below shows the Fund’s transactions in, and earnings from, its investments in affiliates for the three months ended November 30, 2023.
    
  Value
August 31, 2023 		  Purchases
at Cost 		  Proceeds
from Sales 		  Change in
Unrealized
Appreciation 		  Realized
Gain 		  Value
November 30, 2023 		  Dividend
Income
Investments in Affiliated Money Market Funds:                          
Invesco Government & Agency Portfolio, Institutional Class $305   $7,498   $(7,803)   $-   $-   $-   $13
Investments Purchased with Cash Collateral from Securities on Loan:                          
Invesco Private Government Fund 160,121   692,459   (659,347)   -   -   193,233   2,291*
Invesco Private Prime Fund 411,740   1,518,570   (1,433,764)   72   149   496,767   6,025*
Total $572,166   $2,218,527   $(2,100,914)   $72   $149   $690,000   $8,329
    
* Represents the income earned on the investment of cash collateral. Does not include rebates and fees paid to lending agent or premiums received from borrowers, if any.
    
(e) The rate shown is the 7-day SEC standardized yield as of November 30, 2023.
(f) The security has been segregated to satisfy the commitment to return the cash collateral received in securities lending transactions upon the borrower’s return of the securities loaned.  
The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.
See accompanying notes which are an integral part of this schedule.
Schedule of Investments(a)
Invesco NASDAQ 100 ETF (QQQM)
November 30, 2023
(Unaudited)
  Shares   Value
Common Stocks & Other Equity Interests-99.96%
Communication Services-15.48%
Alphabet, Inc., Class A(b)
  3,769,817   $499,613,847
Alphabet, Inc., Class C(b)
  3,685,294   493,534,573
Charter Communications, Inc., Class A(b)
  203,488   81,421,653
Comcast Corp., Class A
  5,611,506   235,065,986
Electronic Arts, Inc.
  368,991   50,924,448
Meta Platforms, Inc., Class A(b)
  1,979,252   647,512,292
Netflix, Inc.(b)
  604,063   286,307,740
Sirius XM Holdings, Inc.(c)
  5,227,551   24,464,939
T-Mobile US, Inc.
  1,604,038   241,327,517
Trade Desk, Inc. (The), Class A(b)(c)
  606,985   42,768,163
Warner Bros Discovery, Inc.(b)
  3,311,839   34,608,718
        2,637,549,876
Consumer Discretionary-14.21%
Airbnb, Inc., Class A(b)
  579,531   73,217,946
Amazon.com, Inc.(b)
  6,553,210   957,358,449
Booking Holdings, Inc.(b)
  49,041   153,287,454
eBay, Inc.
  723,993   29,690,953
JD.com, Inc., ADR (China)(c)
  617,267   16,931,634
Lucid Group, Inc.(b)(c)
  3,089,415   13,037,331
lululemon athletica, inc.(b)(c)
  165,729   74,047,717
Marriott International, Inc., Class A
  405,630   82,221,201
MercadoLibre, Inc. (Brazil)(b)
  68,091   110,338,742
O’Reilly Automotive, Inc., Class R(b)
  82,310   80,859,698
PDD Holdings, Inc., ADR (China)(b)(c)
  886,102   130,646,879
Ross Stores, Inc.
  463,974   60,492,930
Starbucks Corp.
  1,561,902   155,096,869
Tesla, Inc.(b)
  2,016,254   484,062,260
        2,421,290,063
Consumer Staples-6.24%
Costco Wholesale Corp.(c)
  604,545   358,338,003
Dollar Tree, Inc.(b)(c)
  299,429   37,006,430
Keurig Dr Pepper, Inc.
  1,901,452   60,028,840
Kraft Heinz Co. (The)
  1,671,128   58,673,304
Mondelez International, Inc., Class A(c)
  1,851,600   131,574,696
Monster Beverage Corp.(b)
  1,425,295   78,605,019
PepsiCo, Inc.
  1,875,994   315,711,030
Walgreens Boots Alliance, Inc.
  1,172,756   23,384,755
        1,063,322,077
Energy-0.50%
Baker Hughes Co., Class A
  1,373,603   46,359,101
Diamondback Energy, Inc.
  243,445   37,590,343
        83,949,444
Financials-0.51%
PayPal Holdings, Inc.(b)
  1,493,525   86,041,975
Health Care-6.53%
Align Technology, Inc.(b)
  104,332   22,306,182
Amgen, Inc.
  729,129   196,602,344
AstraZeneca PLC, ADR (United Kingdom)(c)
  792,080   51,160,447
Biogen, Inc.(b)
  197,573   46,247,888
DexCom, Inc.(b)
  528,174   61,014,661
GE HealthCare Technologies, Inc.
  618,063   42,312,593
Gilead Sciences, Inc.(c)
  1,695,429   129,869,861
IDEXX Laboratories, Inc.(b)(c)
  113,381   52,815,137
Illumina, Inc.(b)
  215,115   21,930,974
Intuitive Surgical, Inc.(b)
  478,126   148,620,686
Moderna, Inc.(b)(c)
  518,691   40,302,291
Regeneron Pharmaceuticals, Inc.(b)
  145,615   119,959,093
  Shares   Value
Health Care-(continued)
Seagen, Inc.(b)(c)
  255,378   $54,449,143
Vertex Pharmaceuticals, Inc.(b)(c)
  351,157   124,594,015
        1,112,185,315
Industrials-4.77%
Automatic Data Processing, Inc.
  560,893   128,960,519
Cintas Corp.
  138,417   76,579,205
Copart, Inc.(b)
  1,298,268   65,199,019
CSX Corp.
  2,729,179   88,152,482
Fastenal Co.
  776,452   46,563,826
Honeywell International, Inc.
  903,484   177,010,585
Old Dominion Freight Line, Inc.
  148,699   57,852,833
PACCAR, Inc.(c)
  710,816   65,267,125
Paychex, Inc.
  490,073   59,774,204
Verisk Analytics, Inc.
  197,821   47,759,924
        813,119,722
Information Technology-50.24%
Adobe, Inc.(b)
  620,967   379,417,047
Advanced Micro Devices, Inc.(b)
  2,202,820   266,893,671
Analog Devices, Inc.
  678,306   124,387,754
ANSYS, Inc.(b)
  117,979   34,610,319
Apple, Inc.
  9,929,390   1,886,087,631
Applied Materials, Inc.
  1,140,463   170,818,548
ASML Holding N.V., New York Shares (Netherlands)
  117,887   80,606,415
Atlassian Corp., Class A(b)(c)
  209,008   39,910,078
Autodesk, Inc.(b)(c)
  290,683   63,493,888
Broadcom, Inc.
  562,454   520,680,541
Cadence Design Systems, Inc.(b)
  370,063   101,127,116
Cisco Systems, Inc.
  5,555,172   268,759,221
Cognizant Technology Solutions Corp., Class A
  687,612   48,394,133
CrowdStrike Holdings, Inc., Class A(b)
  307,672   72,915,187
Datadog, Inc., Class A(b)
  406,640   47,402,025
Enphase Energy, Inc.(b)(c)
  185,044   18,693,145
Fortinet, Inc.(b)
  1,068,054   56,136,918
GLOBALFOUNDRIES, Inc.(b)(c)
  744,757   39,986,003
Intel Corp.
  5,709,558   255,217,243
Intuit, Inc.(c)
  381,247   217,867,411
KLA Corp.
  186,701   101,681,099
Lam Research Corp.
  180,354   129,119,036
Marvell Technology, Inc.(c)
  1,173,553   65,402,109
Microchip Technology, Inc.
  741,937   61,907,223
Micron Technology, Inc.
  1,490,187   113,433,034
Microsoft Corp.
  4,718,609   1,787,928,136
NVIDIA Corp.
  1,568,942   733,794,173
NXP Semiconductors N.V. (China)
  350,799   71,591,060
ON Semiconductor Corp.(b)(c)
  586,943   41,866,644
Palo Alto Networks, Inc.(b)(c)
  416,020   122,763,342
QUALCOMM, Inc.
  1,521,476   196,346,478
Synopsys, Inc.(b)
  207,089   112,496,957
Texas Instruments, Inc.
  1,237,583   188,991,300
Workday, Inc., Class A(b)
  281,126   76,106,431
Zoom Video Communications, Inc., Class A(b)(c)
  345,423   23,430,042
Zscaler, Inc.(b)(c)
  198,876   39,283,976
        8,559,545,334
Real Estate-0.27%
CoStar Group, Inc.(b)
  555,193   46,103,227
Utilities-1.21%
American Electric Power Co., Inc.
  701,076   55,770,596
See accompanying notes which are an integral part of this schedule.
Invesco NASDAQ 100 ETF (QQQM)—(continued)
November 30, 2023
(Unaudited)
  Shares   Value
Utilities-(continued)
Constellation Energy Corp.
  437,418   $52,945,075
Exelon Corp.
  1,353,794   52,134,607
Xcel Energy, Inc.
  749,834   45,619,900
        206,470,178
TOTAL INVESTMENTS IN SECURITIES

(excluding investments purchased with cash collateral from securities on loan)-99.96%

(Cost $15,370,930,210)
  17,029,577,211
Investments Purchased with Cash Collateral from Securities on Loan
Money Market Funds-2.01%
Invesco Private Government Fund, 5.32%(d)(e)(f)
  96,136,251   96,136,251
  Shares   Value
Money Market Funds-(continued)
Invesco Private Prime Fund, 5.55%(d)(e)(f)
  247,041,543   $247,140,360
Total Investments Purchased with Cash Collateral from Securities on Loan

(Cost $343,226,626)
  343,276,611
TOTAL INVESTMENTS IN SECURITIES-101.97%

(Cost $15,714,156,836)
  17,372,853,822
OTHER ASSETS LESS LIABILITIES-(1.97)%
  (336,048,512)
NET ASSETS-100.00%
  $17,036,805,310
 
Investment Abbreviations:
ADR -American Depositary Receipt
    
Notes to Schedule of Investments:
(a) Industry and/or sector classifications used in this report are generally according to the Global Industry Classification Standard, which was developed by and is the exclusive property and a service mark of MSCI Inc. and Standard & Poor’s.
(b) Non-income producing security.
(c) All or a portion of this security was out on loan at November 30, 2023.
(d) Affiliated holding. Affiliated holdings are investments in entities which are under common ownership or control of Invesco Ltd. or are investments in entities in which the Fund owns 5% or more of the outstanding voting securities. The table below shows the Fund’s transactions in, and earnings from, its investments in affiliates for the three months ended November 30, 2023.
    
  Value
August 31, 2023 		  Purchases
at Cost 		  Proceeds
from Sales 		  Change in
Unrealized
Appreciation 		  Realized
Gain 		  Value
November 30, 2023 		  Dividend
Income
Investments in Affiliated Money Market Funds:                          
Invesco Government & Agency Portfolio, Institutional Class $5,153,075   $30,508,948   $(35,662,023)   $-   $-   $-   $41,844
Investments Purchased with Cash Collateral from Securities on Loan:                          
Invesco Private Government Fund 91,268,225   374,189,262   (369,321,236)   -   -   96,136,251   1,476,941*
Invesco Private Prime Fund 254,782,461   878,964,309   (886,697,054)   49,985   40,659   247,140,360   3,943,715*
Total $351,203,761   $1,283,662,519   $(1,291,680,313)   $49,985   $40,659   $343,276,611   $5,462,500
    
* Represents the income earned on the investment of cash collateral. Does not include rebates and fees paid to lending agent or premiums received from borrowers, if any.
    
(e) The rate shown is the 7-day SEC standardized yield as of November 30, 2023.
(f) The security has been segregated to satisfy the commitment to return the cash collateral received in securities lending transactions upon the borrower’s return of the securities loaned.  
The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.
See accompanying notes which are an integral part of this schedule.
Schedule of Investments(a)
Invesco NASDAQ Future Gen 200 ETF (QQQS)
November 30, 2023
(Unaudited)
  Shares   Value
Common Stocks & Other Equity Interests-99.91%
Communication Services-1.93%
Bandwidth, Inc., Class A(b)
  2,334   $25,627
DISH Network Corp., Class A(b)(c)
  5,518   20,196
EchoStar Corp., Class A(b)(c)
  1,905   19,945
Roku, Inc., Class A(b)
  413   43,035
        108,803
Consumer Discretionary-6.97%
BRP, Inc.
  440   27,161
Fossil Group, Inc.(b)
  15,829   17,412
Garrett Motion, Inc. (Switzerland)(b)(c)
  4,327   32,020
Gentex Corp.
  1,027   31,231
Gentherm, Inc.(b)
  558   25,623
Goodyear Tire & Rubber Co. (The)(b)
  2,599   36,100
GoPro, Inc., Class A(b)
  9,246   33,378
Helen of Troy Ltd.(b)(c)
  274   28,778
Newell Brands, Inc.
  3,129   23,874
Purple Innovation, Inc.(c)
  15,257   9,466
Qurate Retail, Inc., Class A(b)
  43,282   33,414
Sleep Number Corp.(b)
  1,294   13,121
Sonos, Inc.(b)(c)
  2,439   36,829
Universal Electronics, Inc.(b)
  3,767   29,345
Workhorse Group, Inc.(b)(c)
  42,641   15,850
        393,602
Energy-0.51%
Gevo, Inc.(b)(c)
  25,596   28,924
Health Care-55.57%
Accuray, Inc.(b)
  11,788   30,767
Aclaris Therapeutics, Inc.(b)
  4,426   3,871
Adaptimmune Therapeutics PLC, ADR(b)
  43,060   21,530
Adaptive Biotechnologies Corp.(b)(c)
  4,890   21,418
Agenus, Inc.(b)
  23,991   18,643
Agios Pharmaceuticals, Inc.(b)(c)
  1,224   27,210
Akebia Therapeutics, Inc.(b)(c)
  24,186   25,637
Alector, Inc.(b)(c)
  6,157   33,371
Alkermes PLC(b)
  1,149   27,737
Alphatec Holdings, Inc.(b)
  2,025   24,037
Altimmune, Inc.(b)
  13,261   41,905
Amarin Corp. PLC, ADR (Ireland)(b)
  32,029   25,047
Amicus Therapeutics, Inc.(b)
  2,615   28,817
AnaptysBio, Inc.(b)(c)
  1,704   24,095
AngioDynamics, Inc.(b)
  4,180   27,295
Anika Therapeutics, Inc.(b)
  1,877   41,125
Apyx Medical Corp.(b)
  7,105   16,768
Arbutus Biopharma Corp.(b)(c)
  16,524   33,874
Ardelyx, Inc.(b)(c)
  7,886   35,566
Arrowhead Pharmaceuticals, Inc.(b)(c)
  1,215   25,758
AtriCure, Inc.(b)
  743   26,362
Autolus Therapeutics PLC, ADR (United Kingdom)(b)
  10,436   44,666
Avadel Pharmaceuticals PLC, ADR(b)(c)
  2,486   28,688
Axogen, Inc.(b)
  5,289   34,643
Azenta, Inc.(b)
  595   33,540
Bicycle Therapeutics PLC, ADR (United Kingdom)(b)(c)
  1,523   21,931
BioCryst Pharmaceuticals, Inc.(b)(c)
  4,719   27,748
Bionano Genomics, Inc.(b)
  8,577   13,637
Bluebird Bio, Inc.(b)(c)
  8,896   33,983
Cara Therapeutics, Inc.(b)
  12,882   12,456
Cartesian Therapeutics, Inc.(b)(c)
  27,325   36,889
Cerus Corp.(b)(c)
  17,739   28,560
Chimerix, Inc.(b)
  29,469   28,662
  Shares   Value
Health Care-(continued)
Cidara Therapeutics, Inc.(b)
  42,790   $30,355
Codexis, Inc.(b)
  19,291   45,527
Coherus Biosciences, Inc.(b)(c)
  6,211   13,229
Corcept Therapeutics, Inc.(b)
  1,027   26,158
CorMedix, Inc.(b)(c)
  8,243   26,790
Corvus Pharmaceuticals, Inc.(b)
  15,617   23,894
CytomX Therapeutics, Inc.(b)(c)
  22,364   31,086
DENTSPLY SIRONA, Inc.
  906   28,765
Eagle Pharmaceuticals, Inc.(b)
  1,980   11,583
Editas Medicine, Inc.(b)(c)
  3,771   39,709
Enanta Pharmaceuticals, Inc.(b)(c)
  2,229   20,819
Esperion Therapeutics, Inc.(b)(c)
  20,692   27,520
Eyenovia, Inc.(b)
  17,517   24,874
Fate Therapeutics, Inc.(b)(c)
  13,378   33,311
FibroGen, Inc.(b)(c)
  34,487   19,051
G1 Therapeutics, Inc.(b)(c)
  20,107   37,801
Galera Therapeutics, Inc.(b)
  157,653   22,466
Geron Corp.(b)
  13,827   26,686
Gritstone bio, Inc.(b)
  18,423   23,950
Heron Therapeutics, Inc.(b)(c)
  20,187   24,830
ICU Medical, Inc.(b)(c)
  228   20,009
IGM Biosciences, Inc.(b)(c)
  4,702   31,691
I-Mab, ADR (China)(b)
  17,645   27,526
ImmunoGen, Inc.(b)(c)
  2,118   62,163
InflaRx N.V. (Germany)(b)
  8,382   11,316
Innoviva, Inc.(b)(c)
  2,630   36,425
Inovio Pharmaceuticals, Inc.(b)
  74,554   29,389
Integra LifeSciences Holdings Corp.(b)
  790   30,960
Ionis Pharmaceuticals, Inc.(b)(c)
  834   41,258
Ironwood Pharmaceuticals, Inc.(b)
  3,811   37,729
KalVista Pharmaceuticals, Inc.(b)(c)
  3,095   26,122
Karyopharm Therapeutics, Inc.(b)
  25,865   19,916
Kodiak Sciences, Inc.(b)
  15,266   36,944
Lexicon Pharmaceuticals, Inc.(b)(c)
  19,550   20,723
Ligand Pharmaceuticals, Inc.(b)(c)
  510   29,738
LivaNova PLC(b)(c)
  604   27,089
MacroGenics, Inc.(b)(c)
  7,194   59,063
MannKind Corp.(b)(c)
  7,282   26,361
Merit Medical Systems, Inc.(b)
  513   36,710
Mersana Therapeutics, Inc.(b)
  30,224   49,870
Merus N.V. (Netherlands)(b)
  1,499   37,085
MiMedx Group, Inc.(b)
  4,518   35,105
Mural Oncology PLC (Ireland)(b)
  114   412
NanoString Technologies, Inc.(b)
  12,932   6,431
Nektar Therapeutics(b)
  56,359   27,616
NGM Biopharmaceuticals, Inc.(b)
  17,517   13,083
Ocugen, Inc.(b)
  77,789   30,081
Omeros Corp.(b)(c)
  9,569   20,956
OmniAb Operations, Inc., Rts., expiring 11/02/2027(b)(d)
  83   0
OmniAb Operations, Inc., Rts., expiring 11/02/2027(b)(d)
  83   0
Omnicell, Inc.(b)
  582   19,416
OPKO Health, Inc.(b)
  18,371   26,822
Oramed Pharmaceuticals, Inc. (Israel)(b)
  10,094   22,409
OraSure Technologies, Inc.(b)
  5,191   37,998
Orthofix Medical, Inc.(b)
  1,565   17,293
Pacific Biosciences of California, Inc.(b)(c)
  2,935   24,889
PDS Biotechnology Corp.(b)(c)
  5,720   30,087
Phibro Animal Health Corp., Class A
  2,404   23,054
ProQR Therapeutics N.V. (Netherlands)(b)
  21,124   32,742
PTC Therapeutics, Inc.(b)(c)
  838   19,291
See accompanying notes which are an integral part of this schedule.
Invesco NASDAQ Future Gen 200 ETF (QQQS)—(continued)
November 30, 2023
(Unaudited)
  Shares   Value
Health Care-(continued)
Quanterix Corp.(b)
  1,254   $30,058
Rigel Pharmaceuticals, Inc.(b)
  29,493   33,622
Sangamo Therapeutics, Inc.(b)
  34,156   14,687
Scilex Holding Co., Class C (Singapore)(b)
  2,541   3,176
Seres Therapeutics, Inc.(b)(c)
  9,596   9,980
SI-BONE, Inc.(b)
  1,468   27,833
SIGA Technologies, Inc.(c)
  7,303   39,655
Supernus Pharmaceuticals, Inc.(b)(c)
  1,046   28,503
SurModics, Inc.(b)
  911   29,899
Sutro Biopharma, Inc.(b)
  6,970   18,192
Tactile Systems Technology, Inc.(b)(c)
  1,747   23,287
Theravance Biopharma, Inc.(b)(c)
  3,524   36,932
Twist Bioscience Corp.(b)(c)
  1,528   36,748
uniQure N.V. (Netherlands)(b)
  3,801   25,771
Vanda Pharmaceuticals, Inc.(b)
  6,464   24,046
Varex Imaging Corp.(b)(c)
  1,707   32,177
Vaxart, Inc.(b)
  40,771   29,151
Veradigm, Inc.(b)(c)
  2,509   28,803
Verastem, Inc.(b)
  3,392   23,371
Voyager Therapeutics, Inc.(b)
  3,304   23,987
WaVe Life Sciences Ltd.(b)
  7,712   40,951
X4 Pharmaceuticals, Inc.(b)
  25,865   20,175
Xencor, Inc.(b)
  1,526   27,987
        3,139,403
Industrials-4.78%
AeroVironment, Inc.(b)(c)
  346   47,613
Astronics Corp.(b)
  1,913   28,408
Ballard Power Systems, Inc. (Canada)(b)(c)
  7,996   28,066
Interface, Inc.
  3,246   32,817
LSI Industries, Inc.
  2,131   27,937
Matthews International Corp., Class A
  795   27,149
MillerKnoll, Inc.
  1,756   45,305
SunPower Corp.(b)
  4,624   19,190
TPI Composites, Inc.(b)(c)
  6,556   13,833
        270,318
Information Technology-28.97%
8x8, Inc.(b)(c)
  10,337   31,941
Aehr Test Systems(b)(c)
  649   14,901
Alpha & Omega Semiconductor Ltd.(b)
  1,065   22,780
Amkor Technology, Inc.
  1,200   33,804
Atomera, Inc.(b)(c)
  5,279   36,372
Aviat Networks, Inc.(b)
  951   28,825
Axcelis Technologies, Inc.(b)(c)
  175   21,749
Bel Fuse, Inc., Class B
  642   34,732
Cirrus Logic, Inc.(b)(c)
  409   31,047
CommScope Holding Co., Inc.(b)
  9,912   16,553
CommVault Systems, Inc.(b)
  492   36,201
Comtech Telecommunications Corp.
  3,337   39,409
Daktronics, Inc.(b)(c)
  4,008   41,804
Digimarc Corp.(b)(c)
  1,026   34,258
Dropbox, Inc., Class A(b)
  1,209   34,070
Extreme Networks, Inc.(b)
  1,206   19,465
FARO Technologies, Inc.(b)(c)
  2,114   38,834
GSI Technology, Inc.(b)
  10,799   29,913
Himax Technologies, Inc., ADR (Taiwan)(c)
  5,487   31,331
Hollysys Automation Technologies Ltd. (China)(b)
  1,778   40,538
Immersion Corp.
  4,784   31,000
Infinera Corp.(b)(c)
  7,073   27,514
InterDigital, Inc.
  387   38,669
IPG Photonics Corp.(b)(c)
  310   29,686
Itron, Inc.(b)(c)
  491   33,084
  Shares   Value
Information Technology-(continued)
Kimball Electronics, Inc.(b)(c)
  1,112   $27,400
Kulicke & Soffa Industries, Inc. (Singapore)(c)
  648   33,385
Littelfuse, Inc.
  126   29,333
LivePerson, Inc.(b)
  7,883   22,388
Lumentum Holdings, Inc.(b)
  621   26,579
Luna Innovations, Inc.(b)(c)
  4,866   30,996
MaxLinear, Inc.(b)
  1,409   26,391
MicroVision, Inc.(b)(c)
  13,325   33,579
Mitek Systems, Inc.(b)(c)
  3,007   33,949
MKS Instruments, Inc.
  336   27,737
NETGEAR, Inc.(b)
  2,547   34,741
nLight, Inc.(b)(c)
  2,942   38,893
Nova Ltd. (Israel)(b)(c)
  257   33,053
OSI Systems, Inc.(b)(c)
  246   30,329
Power Integrations, Inc.
  399   30,488
Rambus, Inc.(b)(c)
  594   40,196
Ribbon Communications, Inc.(b)
  11,185   23,824
Semtech Corp.(b)(c)
  1,266   20,724
Silicon Laboratories, Inc.(b)
  247   26,026
Soundhound AI, Inc., Class A(b)(c)
  13,138   28,115
Stratasys Ltd.(b)(c)
  2,286   25,238
Synaptics, Inc.(b)
  383   38,775
Turtle Beach Corp.(b)
  3,089   34,937
Universal Display Corp.(c)
  207   35,024
Veeco Instruments, Inc.(b)(c)
  1,151   32,838
Verint Systems, Inc.(b)
  1,022   25,111
Viasat, Inc.(b)(c)
  1,193   24,397
Viavi Solutions, Inc.(b)(c)
  3,214   25,969
Vuzix Corp.(b)(c)
  8,390   17,619
        1,636,514
Materials-1.18%
Haynes International, Inc.
  688   33,767
Innospec, Inc.
  313   32,887
        66,654
Total Common Stocks & Other Equity Interests

(Cost $7,166,111)
  5,644,218
Money Market Funds-0.06%
Invesco Government & Agency Portfolio, Institutional Class, 5.28%(e)(f)

(Cost $3,042)
  3,042   3,042
TOTAL INVESTMENTS IN SECURITIES

(excluding investments purchased with cash collateral from securities on loan)-99.97%

(Cost $7,169,153)
  5,647,260
Investments Purchased with Cash Collateral from Securities on Loan
Money Market Funds-41.04%
Invesco Private Government Fund, 5.32%(e)(f)(g)
  689,286   689,286
Invesco Private Prime Fund, 5.55%(e)(f)(g)
  1,628,481   1,629,132
Total Investments Purchased with Cash Collateral from Securities on Loan

(Cost $2,318,059)
  2,318,418
TOTAL INVESTMENTS IN SECURITIES-141.01%

(Cost $9,487,212)
  7,965,678
OTHER ASSETS LESS LIABILITIES-(41.01)%
  (2,316,462)
NET ASSETS-100.00%
  $5,649,216
 
See accompanying notes which are an integral part of this schedule.
Invesco NASDAQ Future Gen 200 ETF (QQQS)—(continued)
November 30, 2023
(Unaudited)
Investment Abbreviations:
ADR -American Depositary Receipt
Rts. -Rights
    
Notes to Schedule of Investments:
(a) Industry and/or sector classifications used in this report are generally according to the Global Industry Classification Standard, which was developed by and is the exclusive property and a service mark of MSCI Inc. and Standard & Poor’s.
(b) Non-income producing security.
(c) All or a portion of this security was out on loan at November 30, 2023.
(d) Security valued using significant unobservable inputs (Level 3). See Note 1.
(e) Affiliated holding. Affiliated holdings are investments in entities which are under common ownership or control of Invesco Ltd. or are investments in entities in which the Fund owns 5% or more of the outstanding voting securities. The table below shows the Fund’s transactions in, and earnings from, its investments in affiliates for the three months ended November 30, 2023.
    
  Value
August 31, 2023 		  Purchases
at Cost 		  Proceeds
from Sales 		  Change in
Unrealized
Appreciation 		  Realized
Gain 		  Value
November 30, 2023 		  Dividend
Income
Investments in Affiliated Money Market Funds:                          
Invesco Government & Agency Portfolio, Institutional Class $1,428   $66,960   $(65,346)   $-   $-   $3,042   $30
Investments Purchased with Cash Collateral from Securities on Loan:                          
Invesco Private Government Fund 626,570   1,209,710   (1,146,994)   -   -   689,286   8,524*
Invesco Private Prime Fund 1,609,220   2,302,396   (2,283,160)   360   316   1,629,132   22,563*
Total $2,237,218   $3,579,066   $(3,495,500)   $360   $316   $2,321,460   $31,117
    
* Represents the income earned on the investment of cash collateral. Does not include rebates and fees paid to lending agent or premiums received from borrowers, if any.
    
(f) The rate shown is the 7-day SEC standardized yield as of November 30, 2023.
(g) The security has been segregated to satisfy the commitment to return the cash collateral received in securities lending transactions upon the borrower’s return of the securities loaned.  
The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.
See accompanying notes which are an integral part of this schedule.
Schedule of Investments(a)
Invesco NASDAQ Next Gen 100 ETF (QQQJ)
November 30, 2023
(Unaudited)
  Shares   Value
Common Stocks & Other Equity Interests-99.97%
Communication Services-10.01%
Baidu, Inc., ADR (China)(b)
  70,571   $8,373,955
Fox Corp., Class A(c)
  130,440   3,853,197
Fox Corp., Class B
  121,134   3,350,566
Liberty Broadband Corp., Class A(b)(c)
  9,372   777,314
Liberty Broadband Corp., Class C(b)
  64,766   5,383,350
Liberty Global Ltd., Class A (Bermuda)(b)
  88,104   1,409,664
Liberty Global Ltd., Class C (Bermuda)(b)(c)
  108,464   1,826,534
Liberty Media Corp.-Liberty Formula One(b)
  107,012   6,812,384
Liberty Media Corp.-Liberty Live, Series C(b)
  4,576   156,728
Match Group, Inc.(b)
  142,986   4,629,887
News Corp., Class A(c)
  195,178   4,301,723
News Corp., Class B(c)
  98,643   2,272,735
Paramount Global, Class B(c)
  313,860   4,510,168
Take-Two Interactive Software, Inc.(b)(c)
  87,576   13,854,523
ZoomInfo Technologies, Inc., Class A(b)(c)
  206,425   2,966,327
        64,479,055
Consumer Discretionary-10.79%
Caesars Entertainment, Inc.(b)
  110,700   4,950,504
Etsy, Inc.(b)(c)
  63,250   4,794,983
Expedia Group, Inc.(b)
  71,140   9,687,845
Five Below, Inc.(b)(c)
  28,634   5,396,364
Hasbro, Inc.(c)
  71,337   3,310,750
LKQ Corp.
  137,570   6,125,992
Pool Corp.(c)
  20,079   6,973,838
Tractor Supply Co.(c)
  56,024   11,373,432
Trip.com Group Ltd., ADR (China)(b)(c)
  171,975   6,050,081
Ulta Beauty, Inc.(b)
  25,400   10,820,146
        69,483,935
Consumer Staples-3.04%
Casey’s General Stores, Inc.
  19,229   5,295,666
Coca-Cola Europacific Partners PLC (United Kingdom)(c)
  235,512   14,281,448
        19,577,114
Energy-2.36%
APA Corp.
  157,988   5,687,568
Chesapeake Energy Corp.(c)
  68,053   5,465,336
New Fortress Energy, Inc.(c)
  105,424   4,056,716
        15,209,620
Financials-0.92%
Jack Henry & Associates, Inc.
  37,500   5,950,875
Health Care-21.63%
Acadia Healthcare Co., Inc.(b)
  47,396   3,459,434
Alnylam Pharmaceuticals, Inc.(b)(c)
  64,495   10,851,284
Argenx SE, ADR (Netherlands)(b)
  15,367   6,924,524
BeiGene Ltd., ADR (China)(b)(c)
  21,635   4,044,447
BioMarin Pharmaceutical, Inc.(b)
  97,081   8,842,137
BioNTech SE, ADR (Germany)(b)(c)
  48,039   4,823,596
Bio-Techne Corp.
  81,329   5,115,594
Bruker Corp.
  75,513   4,915,141
Henry Schein, Inc.(b)
  67,146   4,480,653
Hologic, Inc.(b)
  126,352   9,008,898
ICON PLC(b)(c)
  42,377   11,312,116
Incyte Corp.(b)
  115,222   6,261,163
Insulet Corp.(b)(c)
  35,901   6,788,520
Jazz Pharmaceuticals PLC(b)
  32,461   3,837,864
Karuna Therapeutics, Inc.(b)(c)
  19,365   3,702,782
Neurocrine Biosciences, Inc.(b)
  50,209   5,853,867
Novocure Ltd.(b)(c)
  54,823   672,678
  Shares   Value
Health Care-(continued)
R1 RCM, Inc.(b)(c)
  215,422   $2,279,165
Repligen Corp.(b)(c)
  28,670   4,508,358
Royalty Pharma PLC, Class A
  230,831   6,248,595
Sanofi S.A., ADR
  145,004   6,778,937
Sarepta Therapeutics, Inc.(b)(c)
  47,961   3,898,270
Shockwave Medical, Inc.(b)(c)
  18,899   3,298,820
United Therapeutics Corp.(b)(c)
  24,135   5,792,400
Viatris, Inc.
  616,777   5,662,013
        139,361,256
Industrials-11.84%
American Airlines Group, Inc.(b)(c)
  335,949   4,175,846
Avis Budget Group, Inc.(b)(c)
  19,917   3,641,823
Axon Enterprise, Inc.(b)
  38,569   8,865,856
C.H. Robinson Worldwide, Inc.
  59,870   4,912,334
Grab Holdings Ltd., Class A (Singapore)(b)(c)
  1,949,273   5,925,790
J.B. Hunt Transport Services, Inc.
  53,337   9,881,746
Lincoln Electric Holdings, Inc.(c)
  29,517   5,846,137
Middleby Corp. (The)(b)(c)
  27,560   3,478,899
Nordson Corp.
  29,319   6,899,934
Paylocity Holding Corp.(b)
  28,755   4,505,046
SS&C Technologies Holdings, Inc.
  127,562   7,176,638
Tetra Tech, Inc.
  27,376   4,329,514
United Airlines Holdings, Inc.(b)
  168,640   6,644,416
        76,283,979
Information Technology-36.78%
Akamai Technologies, Inc.(b)
  78,267   9,042,187
Amdocs Ltd.
  61,201   5,126,808
Bentley Systems, Inc., Class B
  145,700   7,585,142
CDW Corp.
  69,104   14,572,652
Check Point Software Technologies Ltd. (Israel)(b)
  60,359   8,812,414
Cognex Corp.
  88,588   3,339,768
DocuSign, Inc.(b)(c)
  104,053   4,484,684
Entegris, Inc.
  77,466   8,087,450
F5, Inc.(b)
  30,493   5,220,097
First Solar, Inc.(b)
  55,118   8,696,518
Flex Ltd.(b)
  229,645   5,844,465
Gen Digital, Inc.
  328,791   7,259,705
Logitech International S.A., Class R (Switzerland)(c)
  81,315   7,131,326
Manhattan Associates, Inc.(b)
  31,711   7,073,139
MongoDB, Inc.(b)
  36,388   15,127,947
Monolithic Power Systems, Inc.
  24,634   13,517,168
NetApp, Inc.
  107,728   9,845,262
Okta, Inc.(b)
  80,602   5,404,364
Open Text Corp. (Canada)
  139,443   5,597,242
PTC, Inc.(b)
  61,290   9,644,594
Qorvo, Inc.(b)
  50,342   4,858,003
Seagate Technology Holdings PLC(c)
  107,017   8,465,045
Skyworks Solutions, Inc.
  82,265   7,973,946
SolarEdge Technologies, Inc.(b)(c)
  29,084   2,308,688
Splunk, Inc.(b)
  86,484   13,105,785
Teradyne, Inc.(c)
  79,190   7,303,694
Trimble, Inc.(b)
  127,682   5,924,445
VeriSign, Inc.(b)
  53,155   11,279,491
Western Digital Corp.(b)
  166,139   8,026,175
Zebra Technologies Corp., Class A(b)
  26,400   6,256,272
        236,914,476
Materials-1.58%
Steel Dynamics, Inc.
  85,434   10,177,752
See accompanying notes which are an integral part of this schedule.
Invesco NASDAQ Next Gen 100 ETF (QQQJ)—(continued)
November 30, 2023
(Unaudited)
  Shares   Value
Utilities-1.02%
Alliant Energy Corp.
  129,942   $6,571,167
TOTAL INVESTMENTS IN SECURITIES

(excluding investments purchased with cash collateral from securities on loan)-99.97%

(Cost $721,908,087)
  644,009,229
Investments Purchased with Cash Collateral from Securities on Loan
Money Market Funds-17.72%
Invesco Private Government Fund, 5.32%(d)(e)(f)
  26,171,246   26,171,246
  Shares   Value
Money Market Funds-(continued)
Invesco Private Prime Fund, 5.55%(d)(e)(f)
  87,944,376   $87,979,554
Total Investments Purchased with Cash Collateral from Securities on Loan

(Cost $114,135,847)
  114,150,800
TOTAL INVESTMENTS IN SECURITIES-117.69%

(Cost $836,043,934)
  758,160,029
OTHER ASSETS LESS LIABILITIES-(17.69)%
  (113,941,228)
NET ASSETS-100.00%
  $644,218,801
 
Investment Abbreviations:
ADR -American Depositary Receipt
    
Notes to Schedule of Investments:
(a) Industry and/or sector classifications used in this report are generally according to the Global Industry Classification Standard, which was developed by and is the exclusive property and a service mark of MSCI Inc. and Standard & Poor’s.
(b) Non-income producing security.
(c) All or a portion of this security was out on loan at November 30, 2023.
(d) Affiliated holding. Affiliated holdings are investments in entities which are under common ownership or control of Invesco Ltd. or are investments in entities in which the Fund owns 5% or more of the outstanding voting securities. The table below shows the Fund’s transactions in, and earnings from, its investments in affiliates for the three months ended November 30, 2023.
    
  Value
August 31, 2023 		  Purchases
at Cost 		  Proceeds
from Sales 		  Change in
Unrealized
Appreciation 		  Realized
Gain 		  Value
November 30, 2023 		  Dividend
Income
Investments in Affiliated Money Market Funds:                          
Invesco Government & Agency Portfolio, Institutional Class $100,009   $1,164,129   $(1,264,138)   $-   $-   $-   $1,465
Investments Purchased with Cash Collateral from Securities on Loan:                          
Invesco Private Government Fund 20,494,896   77,320,577   (71,644,227)   -   -   26,171,246   336,326*
Invesco Private Prime Fund 52,701,161   161,621,530   (126,373,778)   16,419   14,222   87,979,554   907,288*
Total $73,296,066   $240,106,236   $(199,282,143)   $16,419   $14,222   $114,150,800   $1,245,079
    
* Represents the income earned on the investment of cash collateral. Does not include rebates and fees paid to lending agent or premiums received from borrowers, if any.
    
(e) The rate shown is the 7-day SEC standardized yield as of November 30, 2023.
(f) The security has been segregated to satisfy the commitment to return the cash collateral received in securities lending transactions upon the borrower’s return of the securities loaned.  
The valuation policy and a listing of other significant accounting policies are available in the most recent shareholder report.
See accompanying notes which are an integral part of this schedule.
Notes to Quarterly Schedules of Portfolio Holdings
November 30, 2023
(Unaudited)
NOTE 1—Additional Valuation Information
Generally Accepted Accounting Principles ("GAAP") defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, under current market conditions. GAAP establishes a hierarchy that prioritizes the inputs to valuation methods, giving the highest priority to readily available unadjusted quoted prices in an active market for identical assets (Level 1) and the lowest priority to significant unobservable inputs (Level 3), generally when market prices are not readily available. Based on the valuation inputs, the securities or other investments are tiered into one of three levels. Changes in valuation methods may result in transfers in or out of an investment’s assigned level:
Level 1 — Prices are determined using quoted prices in an active market for identical assets.
Level 2 — Prices are determined using other significant observable inputs. Observable inputs are inputs that other market participants may use in pricing a security. These may include quoted prices for similar securities, interest rates, prepayment speeds, credit risk, yield curves, loss severities, default rates, discount rates, volatilities and others.
Level 3 — Prices are determined using significant unobservable inputs. In situations where quoted prices or observable inputs are unavailable (for example, when there is little or no market activity for an investment at the end of the period), unobservable inputs may be used. Unobservable inputs reflect Invesco Capital Management LLC’s assumptions about the factors market participants would use in determining fair value of the securities or instruments and would be based on the best available information.
The following is a summary of the tiered valuation input levels, as of November 30, 2023. The level assigned to the securities valuations may not be an indication of the risk or liquidity associated with investing in those securities. Because of the inherent uncertainties of valuation, the values reflected in the financial statements may materially differ from the value received upon actual sale of those investments.
  Level 1   Level 2   Level 3   Total
Invesco ESG NASDAQ 100 ETF              
Investments in Securities              
Common Stocks & Other Equity Interests $22,539,846   $-   $-   $22,539,846
Money Market Funds 9,152   682,432   -   691,584
Total Investments $22,548,998   $682,432   $-   $23,231,430
Invesco ESG NASDAQ Next Gen 100 ETF              
Investments in Securities              
Common Stocks & Other Equity Interests $3,365,764   $-   $-   $3,365,764
Money Market Funds -   690,000   -   690,000
Total Investments $3,365,764   $690,000   $-   $4,055,764
Invesco NASDAQ 100 ETF              
Investments in Securities              
Common Stocks & Other Equity Interests $17,029,577,211   $-   $-   $17,029,577,211
Money Market Funds -   343,276,611   -   343,276,611
Total Investments $17,029,577,211   $343,276,611   $-   $17,372,853,822
Invesco NASDAQ Future Gen 200 ETF              
Investments in Securities              
Common Stocks & Other Equity Interests $5,644,218   $-   $0   $5,644,218
Money Market Funds 3,042   2,318,418   -   2,321,460
Total Investments $5,647,260   $2,318,418   $0   $7,965,678
Invesco NASDAQ Next Gen 100 ETF              
Investments in Securities              
Common Stocks & Other Equity Interests $644,009,229   $-   $-   $644,009,229
Money Market Funds -   114,150,800   -   114,150,800
Total Investments $644,009,229   $114,150,800   $-   $758,160,029